Back to 
Neuberger Berman Group LLC
Neuberger Berman Group LLC
LGND
4 quarters
Position history for Neuberger Berman Group LLC's holdings in Ligand Pharmaceuticals Incorporated
Yes. Neuberger Berman holds 248,355 shares of LGND (Ligand Pharmaceuticals), worth $78.5M, as of its Q2 2026 13F filing. It increased the position from 1,462 shares in Q1 2026. Neuberger Berman has held LGND since Q3 2025, across 4 quarterly 13F filings. LGND is 0.1% of Neuberger Berman's reported 13F portfolio.
Current Value
$78.5M
Current Shares
248,355
Total Value Change
+$78.3M
Total Shares Change
+247,033
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.